- United States
- /
- Medical Equipment
- /
- NasdaqCM:MDAI
Spectral AI Third Quarter 2024 Earnings: Beats Expectations
Spectral AI (NASDAQ:MDAI) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$8.17m (up 138% from 3Q 2023).
- Net loss: US$1.50m (loss narrowed by 86% from 3Q 2023).
- US$0.084 loss per share (improved from US$0.77 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Spectral AI Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 52%.
Looking ahead, revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 8.2% from a week ago.
Risk Analysis
You should learn about the 7 warning signs we've spotted with Spectral AI (including 2 which are a bit unpleasant).
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:MDAI
Spectral AI
An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
Undervalued with high growth potential.